BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18225579)

  • 21. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
    Begleiter A; Hewitt D; Maksymiuk AW; Ross DA; Bird RP
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2422-6. PubMed ID: 17164365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No association between Helicobacter pylori seropositivity and ornithine decarboxylase (ODC) A317G polymorphism, and no modification by NAD(P)H:qinone oxidoreductase 1 (NQO1) C609T.
    Goto Y; Nishio K; Ishida Y; Kawai S; Osafune T; Naito M; Katsuda N; Hamajima N
    Nagoya J Med Sci; 2007 Jan; 69(1-2):17-22. PubMed ID: 17378176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms.
    Okubo T; Harada S; Higuchi S; Matsushita S
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):68S-71S. PubMed ID: 12960511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin C.
    Basu S; Brown JE; Flannigan GM; Gill JH; Loadman PM; Martin SW; Naylor B; Puri R; Scally AJ; Seargent JM; Shah T; Phillips RM
    Int J Oncol; 2004 Oct; 25(4):921-7. PubMed ID: 15375541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer.
    Song SY; Jeong SY; Park HJ; Park SI; Kim DK; Kim YH; Shin SS; Lee SW; Ahn SD; Kim JH; Lee JS; Choi EK
    Lung Cancer; 2010 May; 68(2):278-82. PubMed ID: 19596483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.
    Xu LL; Wain JC; Miller DP; Thurston SW; Su L; Lynch TJ; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):303-9. PubMed ID: 11319169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
    Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
    Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy.
    Toncheva DI; Von Ahsen N; Atanasova SY; Dimitrov TG; Armstrong VW; Oellerich M
    J Nephrol; 2004; 17(3):384-9. PubMed ID: 15365958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.
    Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R
    Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.
    Sarbia M; Bitzer M; Siegel D; Ross D; Schulz WA; Zotz RB; Kiel S; Geddert H; Kandemir Y; Walter A; Willers R; Gabbert HE
    Int J Cancer; 2003 Nov; 107(3):381-6. PubMed ID: 14506737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.
    Fowke JH; Shu XO; Dai Q; Jin F; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1308-15. PubMed ID: 15298951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease.
    Fong CS; Wu RM; Shieh JC; Chao YT; Fu YP; Kuao CL; Cheng CW
    Clin Chim Acta; 2007 Mar; 378(1-2):136-41. PubMed ID: 17188257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer.
    Olson SH; Carlson MD; Ostrer H; Harlap S; Stone A; Winters M; Ambrosone CB
    Gynecol Oncol; 2004 Jun; 93(3):615-20. PubMed ID: 15196853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of fruit and vegetable consumption and genetic variation on NAD(P)H:quinone oxidoreductase (NQO1) phenotype in an endoscopy-based population.
    Tijhuis MJ; Boerboom AM; Visker MH; Op den Camp L; Nagengast FM; Tan AC; Rietjens IM; Kok FJ; Aarts JM; Kampman E
    Nutr Cancer; 2008; 60(2):204-15. PubMed ID: 18444152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
    Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
    Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
    Masroor M; Jain A; Javid J; Mir R; Prashant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
    Asian Pac J Cancer Prev; 2015; 16(17):7653-8. PubMed ID: 26625776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between hepatocellular carcinoma and the interaction between NQO1 polymorphisms and environmental factors].
    Tan SK; Qiu XQ; Tang GF; Wang WW; Liu S
    Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):833-7. PubMed ID: 23206302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of (NAD(P)H:Quinone oxidoreductase-1, EC 1.6.99.2) 609C-->T and 465C-->T polymorphisms in formalin-fixed, paraffin-embedded human tumour tissue using PCR-RFLP.
    Phillips RM; Basu S; Brown JE; Flannigan GM; Loadman PM; Martin SW; Naylor B; Puri R; Shah T
    Int J Oncol; 2004 Apr; 24(4):1005-10. PubMed ID: 15010841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of the NAD(P)H: quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects.
    Niwa Y; Hirose K; Nakanishi T; Nawa A; Kuzuya K; Tajima K; Hamajima N
    Gynecol Oncol; 2005 Feb; 96(2):423-9. PubMed ID: 15661231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic polymorphisms of MPO, NQO1, GSTP1, UGT1A6 associated with susceptibility of chronic benzene poisoning].
    Sun P; Zhang Z; Wan J; Shao M
    Wei Sheng Yan Jiu; 2007 Jan; 36(1):11-5. PubMed ID: 17424838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.